Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER2 status as a potential predictive biomarker for ovarian clear cell carcinoma.
Kendall Bártů M, Němejcová K, Michálková R, Stružinská I, Hájková N, Hojný J, Krkavcová E, Laco J, Matěj R, Drozenová J, Méhes G, Fabian P, Hausnerová J, Švajdler M, Škapa P, Cibula D, Zima T, Dundr P. Kendall Bártů M, et al. Among authors: hausnerova j. Virchows Arch. 2023 Oct;483(4):497-507. doi: 10.1007/s00428-023-03640-4. Epub 2023 Sep 7. Virchows Arch. 2023. PMID: 37676270
The cytokeratin 17 expression in primary ovarian tumors has diagnostic but not prognostic significance.
Dundr P, Bazalová B, Bártů M, Bosse T, Drozenová J, Fabian P, Fadare O, Hausnerová J, Jakša R, Laco J, Lax SF, Matěj R, McCluggage WG, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I. Dundr P, et al. Among authors: hausnerova j. Virchows Arch. 2022 Aug;481(2):201-212. doi: 10.1007/s00428-022-03338-z. Epub 2022 May 13. Virchows Arch. 2022. PMID: 35554675
A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrations.
Stružinská I, Hájková N, Hojný J, Krkavcová E, Michálková R, Dvořák J, Němejcová K, Matěj R, Laco J, Drozenová J, Fabian P, Hausnerová J, Méhes G, Škapa P, Švajdler M, Cibula D, Frühauf F, Bártů MK, Dundr P. Stružinská I, et al. Among authors: hausnerova j. Diagn Pathol. 2023 Jun 12;18(1):72. doi: 10.1186/s13000-023-01358-0. Diagn Pathol. 2023. PMID: 37303048 Free PMC article.
A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors.
Němejcová K, Bártů MK, Michálková R, Drozenová J, Fabian P, Fadare O, Hausnerová J, Laco J, Matěj R, Méhes G, Singh N, Stolnicu S, Škapa P, Švajdler M, Stružinská I, Cibula D, Kocian R, Lax SF, McCluggage WG, Dundr P. Němejcová K, et al. Among authors: hausnerova j. Diagn Pathol. 2023 Feb 6;18(1):15. doi: 10.1186/s13000-023-01300-4. Diagn Pathol. 2023. PMID: 36740684 Free PMC article.
Primary Mucinous Tumors of the Ovary: An Interobserver Reproducibility and Detailed Molecular Study Reveals Significant Overlap Between Diagnostic Categories.
Dundr P, Bártů M, Bosse T, Bui QH, Cibula D, Drozenová J, Fabian P, Fadare O, Hausnerová J, Hojný J, Hájková N, Jakša R, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Šafanda A, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, Stružinská I, McCluggage WG. Dundr P, et al. Among authors: hausnerova j. Mod Pathol. 2023 Jan;36(1):100040. doi: 10.1016/j.modpat.2022.100040. Mod Pathol. 2023. PMID: 36788074 Free article.
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes.
Hájková N, Bártů MK, Cibula D, Drozenová J, Fabian P, Fadare O, Frühauf F, Hausnerová J, Hojný J, Krkavcová E, Laco J, Lax SF, Matěj R, Méhes G, Michálková R, Němejcová K, Singh N, Stolnicu S, Švajdler M, Zima T, McCluggage WG, Stružinská I, Dundr P. Hájková N, et al. Among authors: hausnerova j. Transl Res. 2023 Oct;260:61-68. doi: 10.1016/j.trsl.2023.05.004. Epub 2023 May 25. Transl Res. 2023. PMID: 37244485 Free article.
WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer.
Kotrbová A, Ovesná P, Gybel' T, Radaszkiewicz T, Bednaříková M, Hausnerová J, Jandáková E, Minář L, Crha I, Weinberger V, Záveský L, Bryja V, Pospíchalová V. Kotrbová A, et al. Among authors: hausnerova j. Theranostics. 2020 Jan 1;10(2):537-552. doi: 10.7150/thno.37423. eCollection 2020. Theranostics. 2020. PMID: 31903136 Free PMC article.
The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study.
van Weelden WJ, Reijnen C, Küsters-Vandevelde HVN, Bulten J, Bult P, Leung S, Visser NCM, Santacana M, Bronsert P, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Huvila J, Koskas M, Weinberger V, Bednarikova M, Hausnerova J, Snijders MPLM, Matias-Guiu X, Amant F; ENITEC-Consortium. van Weelden WJ, et al. Among authors: hausnerova j. Hum Pathol. 2021 Mar;109:80-91. doi: 10.1016/j.humpath.2020.12.003. Epub 2020 Dec 15. Hum Pathol. 2021. PMID: 33338506
39 results